Compile Data Set for Download or QSAR
maximum 50k data
Found 10 with Last Name = 'wolter' and Initial = 'fe'
TargetGlycogen synthase kinase-3 beta(Homo sapiens (Human))
Abbvie Deutschland

US Patent
LigandPNGBDBM292098(US10100048, Example 2.2)
Affinity DataIC50: <100nMT: 2°CAssay Description:Compounds were tested for their ability to inhibit human Glycogen Synthase Kinase-3 beta (hGSK-3β) to phosphorylate biotin-YRRAAVPPSPSLSRHSSPHQ(...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetGlycogen synthase kinase-3 beta(Homo sapiens (Human))
Abbvie Deutschland

US Patent
LigandPNGBDBM292102(3-(6,7-Dihydro-5H-pyrrolo[3,4-b]pyridin-2-yl)-2-ox...)
Affinity DataIC50: <100nMT: 2°CAssay Description:Compounds were tested for their ability to inhibit human Glycogen Synthase Kinase-3 beta (hGSK-3β) to phosphorylate biotin-YRRAAVPPSPSLSRHSSPHQ(...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetGlycogen synthase kinase-3 beta(Homo sapiens (Human))
Abbvie Deutschland

US Patent
LigandPNGBDBM292101(2-Hydroxy-3-(8-hydroxy-5,6,7,8-tetrahydroquinolin-...)
Affinity DataIC50: <100nMT: 2°CAssay Description:Compounds were tested for their ability to inhibit human Glycogen Synthase Kinase-3 beta (hGSK-3β) to phosphorylate biotin-YRRAAVPPSPSLSRHSSPHQ(...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetGlycogen synthase kinase-3 beta(Homo sapiens (Human))
Abbvie Deutschland

US Patent
LigandPNGBDBM292097(3-(5-Hydroxy-5,6,7,8-tetrahydroquinolin-2-yl)-2-ox...)
Affinity DataIC50: <100nMT: 2°CAssay Description:Compounds were tested for their ability to inhibit human Glycogen Synthase Kinase-3 beta (hGSK-3β) to phosphorylate biotin-YRRAAVPPSPSLSRHSSPHQ(...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetGlycogen synthase kinase-3 beta(Homo sapiens (Human))
Abbvie Deutschland

US Patent
LigandPNGBDBM292103(US10100048, Example 6)
Affinity DataIC50: <100nMT: 2°CAssay Description:Compounds were tested for their ability to inhibit human Glycogen Synthase Kinase-3 beta (hGSK-3β) to phosphorylate biotin-YRRAAVPPSPSLSRHSSPHQ(...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetGlycogen synthase kinase-3 beta(Homo sapiens (Human))
Abbvie Deutschland

US Patent
LigandPNGBDBM292099(2-Oxo-3-(5,6,7,8-tetrahydro-1,6-naphthyridin-2-yl)...)
Affinity DataIC50: <100nMT: 2°CAssay Description:Compounds were tested for their ability to inhibit human Glycogen Synthase Kinase-3 beta (hGSK-3β) to phosphorylate biotin-YRRAAVPPSPSLSRHSSPHQ(...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetGlycogen synthase kinase-3 beta(Homo sapiens (Human))
Abbvie Deutschland

US Patent
LigandPNGBDBM292100(2-Hydroxy-3-(5-oxo-5,6,7,8-tetrahydroquinolin-2-yl...)
Affinity DataIC50: <100nMT: 2°CAssay Description:Compounds were tested for their ability to inhibit human Glycogen Synthase Kinase-3 beta (hGSK-3β) to phosphorylate biotin-YRRAAVPPSPSLSRHSSPHQ(...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetPlasminogen(Homo sapiens (Human))
University Of ZüRich

Curated by ChEMBL
LigandPNGBDBM50224807(CHEMBL400366 | cyclo(Pro-Gly-Leu-Val-Met-Phe-Gly-V...)
Affinity DataIC50:  7.80E+4nMAssay Description:Inhibition of plasminMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetCaspase-8(Homo sapiens (Human))
University Of ZüRich

Curated by ChEMBL
LigandPNGBDBM50224807(CHEMBL400366 | cyclo(Pro-Gly-Leu-Val-Met-Phe-Gly-V...)
Affinity DataIC50:  9.30E+4nMAssay Description:Inhibition of human recombinant caspase 8 expressed in Escherichia coliMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetCathepsin B(Bos taurus (bovine))
University Of ZüRich

Curated by ChEMBL
LigandPNGBDBM50224807(CHEMBL400366 | cyclo(Pro-Gly-Leu-Val-Met-Phe-Gly-V...)
Affinity DataIC50: >5.00E+5nMAssay Description:Inhibition of bovine Cathepsin BMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed